{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:25:07Z","timestamp":1793939107431,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Central Government Guidance Fund for Local Science and Technology Development","award":["2024ZY01047"],"award-info":[{"award-number":["2024ZY01047"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LDT23H1901"],"award-info":[{"award-number":["LDT23H1901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05501-5","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:32:10Z","timestamp":1771061530000},"page":"1773-1788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver-specific SLC13A3 modulation alleviates MASLD by regulating NAD+ metabolism"],"prefix":"10.1007","volume":"481","author":[{"given":"Jiangxia","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoran","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"5501_CR1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology"},{"key":"5501_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cld.2004.04.013","volume":"8","author":"MJ Contos","year":"2004","unstructured":"Contos MJ, Choudhury J, Mills AS, Sanyal AJ (2004) The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis 8:481\u2013500. https:\/\/doi.org\/10.1016\/j.cld.2004.04.013","journal-title":"Clin Liver Dis"},{"key":"5501_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.32074\/1591-951x-242","volume":"113","author":"I Cataldo","year":"2021","unstructured":"Cataldo I, Sarcognato S, Sacchi D, Cacciatore M, Baciorri F, Mangia A, Cazzagon N, Guido M (2021) Pathology of non-alcoholic fatty liver disease. Pathologica 113:194\u2013202. https:\/\/doi.org\/10.32074\/1591-951x-242","journal-title":"Pathologica"},{"key":"5501_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-J\u00e4rvinen H, Fan JG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"5501_CR5","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Li X, Li J, Zou B, Wu Y, Ye Q, Huang DQ, Zhao C, Zhang J, Liu C, Chang N, Xing F, Yan S, Wan ZH, Tang NSY, Mayumi M, Liu X, Liu C, Rui F, Yang H, Yang Y, Jin R, Le RHX, Xu Y, Le DM, Barnett S, Stave CD, Cheung R, Zhu Q, Nguyen MH (2022) 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 20:2809-2817e28. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5501_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051442","author":"P Vancells Lujan","year":"2021","unstructured":"Vancells Lujan P, Vi\u00f1as Esmel E, Sacanella Meseguer E (2021) Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development. Nutrients. https:\/\/doi.org\/10.3390\/nu13051442","journal-title":"Nutrients"},{"key":"5501_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.dld.2017.01.147","volume":"49","author":"A Lonardo","year":"2017","unstructured":"Lonardo A, Nascimbeni F, Targher G, Bernardi M, Bonino F, Bugianesi E, Casini A, Gastaldelli A, Marchesini G, Marra F, Miele L (2017) AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. Dig Liver Dis 49:471\u2013483. https:\/\/doi.org\/10.1016\/j.dld.2017.01.147","journal-title":"Dig Liver Dis"},{"key":"5501_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.21037\/atm-20-3760","volume":"9","author":"E Roeb","year":"2021","unstructured":"Roeb E (2021) Non-alcoholic fatty liver diseases: current challenges and future directions. Ann Transl Med 9:726. https:\/\/doi.org\/10.21037\/atm-20-3760","journal-title":"Ann Transl Med"},{"key":"5501_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol 53:362\u2013376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1","journal-title":"J Gastroenterol"},{"key":"5501_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/postgradmedj-2018-136316","volume":"95","author":"E Jennison","year":"2019","unstructured":"Jennison E, Patel J, Scorletti E, Byrne CD (2019) Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J 95:314\u2013322. https:\/\/doi.org\/10.1136\/postgradmedj-2018-136316","journal-title":"Postgrad Med J"},{"key":"5501_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson D, Finck BN (2021) Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol 17:484\u2013495. https:\/\/doi.org\/10.1038\/s41574-021-00507-z","journal-title":"Nat Rev Endocrinol"},{"key":"5501_CR12","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1074\/jbc.M114.554790","volume":"289","author":"A Schlessinger","year":"2014","unstructured":"Schlessinger A, Sun NN, Colas C, Pajor AM (2014) Determinants of substrate and cation transport in the human Na+\/dicarboxylate cotransporter NaDC3. J Biol Chem 289:16998\u201317008. https:\/\/doi.org\/10.1074\/jbc.M114.554790","journal-title":"J Biol Chem"},{"key":"5501_CR13","doi-asserted-by":"publisher","first-page":"C1215","DOI":"10.1152\/ajpcell.2001.280.5.C1215","volume":"280","author":"AM Pajor","year":"2001","unstructured":"Pajor AM, Gangula R, Yao X (2001) Cloning and functional characterization of a high-affinity Na(+)\/dicarboxylate cotransporter from mouse brain. Am J Physiol Cell Physiol 280:C1215\u2013C1223. https:\/\/doi.org\/10.1152\/ajpcell.2001.280.5.C1215","journal-title":"Am J Physiol Cell Physiol"},{"key":"5501_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/b978-0-12-394316-3.00007-7","volume":"70","author":"D Markovich","year":"2012","unstructured":"Markovich D (2012) Sodium-sulfate\/carboxylate cotransporters (SLC13). Curr Top Membr 70:239\u2013256. https:\/\/doi.org\/10.1016\/b978-0-12-394316-3.00007-7","journal-title":"Curr Top Membr"},{"key":"5501_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gerona\/glu198","volume":"71","author":"Y Ma","year":"2016","unstructured":"Ma Y, Bai XY, Du X, Fu B, Chen X (2016) NaDC3 induces premature cellular senescence by promoting transport of Krebs cycle intermediates, increasing NADH, and exacerbating oxidative damage. J Gerontol A Biol Sci Med Sci 71:1\u201312. https:\/\/doi.org\/10.1093\/gerona\/glu198","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"5501_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113734","author":"A Benzi","year":"2021","unstructured":"Benzi A, Grozio A, Spinelli S, Sturla L, Guse AH, De Flora A, Zocchi E, Heeren J, Bruzzone S (2021) Role of CD38 in adipose tissue: tuning coenzyme availability? Nutrients. https:\/\/doi.org\/10.3390\/nu13113734","journal-title":"Nutrients"},{"key":"5501_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas LE, Carnero A (2021) NAD(+) metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther 6:2. https:\/\/doi.org\/10.1038\/s41392-020-00354-w","journal-title":"Signal Transduct Target Ther"},{"key":"5501_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dnarep.2014.09.004","volume":"23","author":"E Fouquerel","year":"2014","unstructured":"Fouquerel E, Sobol RW (2014) ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death. DNA Repair Amst 23:27\u201332. https:\/\/doi.org\/10.1016\/j.dnarep.2014.09.004","journal-title":"DNA Repair Amst"},{"key":"5501_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12508","author":"G Sultani","year":"2017","unstructured":"Sultani G, Samsudeen AF, Osborne B, Turner N (2017) NAD(+)\u202f: A key metabolic regulator with great therapeutic potential. J Neuroendocrinol. https:\/\/doi.org\/10.1111\/jne.12508","journal-title":"J Neuroendocrinol"},{"key":"5501_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrendo.2015.117","volume":"11","author":"A Garten","year":"2015","unstructured":"Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W (2015) Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol 11:535\u201346. https:\/\/doi.org\/10.1038\/nrendo.2015.117","journal-title":"Nat Rev Endocrinol"},{"key":"5501_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9090180","author":"M Guarino","year":"2019","unstructured":"Guarino M, Dufour JF (2019) Nicotinamide and NAFLD: is there nothing new under the sun? Metabolites. https:\/\/doi.org\/10.3390\/metabo9090180","journal-title":"Metabolites"},{"key":"5501_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1113\/jp280908","volume":"600","author":"M Dall","year":"2022","unstructured":"Dall M, Hassing AS, Treebak JT (2022) NAD(+) and NAFLD - caution, causality and careful optimism. J Physiol 600:1135\u20131154. https:\/\/doi.org\/10.1113\/jp280908","journal-title":"J Physiol"},{"key":"5501_CR23","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1111\/bph.13513","volume":"173","author":"CC Zhou","year":"2016","unstructured":"Zhou CC, Yang X, Hua X, Liu J, Fan MB, Li GQ, Song J, Xu TY, Li ZY, Guan YF, Wang P, Miao CY (2016) Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. Br J Pharmacol 173:2352\u20132368. https:\/\/doi.org\/10.1111\/bph.13513","journal-title":"Br J Pharmacol"},{"key":"5501_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/dom.13520","volume":"21","author":"M Shimizu","year":"2019","unstructured":"Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y (2019) Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. Diabetes Obes Metab 21:285\u2013292. https:\/\/doi.org\/10.1111\/dom.13520","journal-title":"Diabetes Obes Metab"},{"key":"5501_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056681","volume":"8","author":"T Fukuzawa","year":"2013","unstructured":"Fukuzawa T, Fukazawa M, Ueda O, Shimada H, Kito A, Kakefuda M, Kawase Y, Wada NA, Goto C, Fukushima N, Jishage K, Honda K, King GL, Kawabe Y (2013) SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose. PLoS One 8:e56681. https:\/\/doi.org\/10.1371\/journal.pone.0056681","journal-title":"PLoS One"},{"key":"5501_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E (2018) Bile acids in glucose metabolism in health and disease. J Exp Med 215:383\u2013396. https:\/\/doi.org\/10.1084\/jem.20171965","journal-title":"J Exp Med"},{"key":"5501_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K (2008) Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7:678\u2013693. https:\/\/doi.org\/10.1038\/nrd2619","journal-title":"Nat Rev Drug Discov"},{"key":"5501_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0004563218817798","volume":"56","author":"ER McGlone","year":"2019","unstructured":"McGlone ER, Bloom SR (2019) Bile acids and the metabolic syndrome. Ann Clin Biochem 56:326\u2013337. https:\/\/doi.org\/10.1177\/0004563218817798","journal-title":"Ann Clin Biochem"},{"key":"5501_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf4823","volume":"8","author":"A Rao","year":"2016","unstructured":"Rao A, Kosters A, Mells JE, Zhang W, Setchell KD, Amanso AM, Wynn GM, Xu T, Keller BT, Yin H, Banton S, Jones DP, Wu H, Dawson PA, Karpen SJ (2016) Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice. Sci Transl Med 8:357ra122. https:\/\/doi.org\/10.1126\/scitranslmed.aaf4823","journal-title":"Sci Transl Med"},{"key":"5501_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00424-013-1388-8","volume":"466","author":"D Markovich","year":"2014","unstructured":"Markovich D (2014) Na+-sulfate cotransporter SLC13A1. Pflugers Arch 466:131\u20137. https:\/\/doi.org\/10.1007\/s00424-013-1388-8","journal-title":"Pflugers Arch"},{"key":"5501_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.26211","volume":"90","author":"Y Wang","year":"2021","unstructured":"Wang Y, Hull V, Sternbach S, Popovich B, Burns T, McDonough J, Guo F, Pleasure D (2021) Ablating the transporter Sodium-Dependent dicarboxylate transporter 3 prevents leukodystrophy in Canavan disease mice. Ann Neurol 90:845\u2013850. https:\/\/doi.org\/10.1002\/ana.26211","journal-title":"Ann Neurol"},{"key":"5501_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygeno.2008.06.004","volume":"92","author":"JL Bento","year":"2008","unstructured":"Bento JL, Palmer ND, Zhong M, Roh B, Lewis JP, Wing MR, Pandya H, Freedman BI, Langefeld CD, Rich SS, Bowden DW, Mychaleckyj JC (2008) Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. Genomics 92:226\u2013234. https:\/\/doi.org\/10.1016\/j.ygeno.2008.06.004","journal-title":"Genomics"},{"key":"5501_CR33","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.2353\/ajpath.2009.080888","volume":"174","author":"W Ju","year":"2009","unstructured":"Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ Jr., Dikman S, Schr\u00f6ppel B, Thomas DB, Schlondorff D, Kretzler M, B\u00f6ttinger EP (2009) Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol 174:2073\u201385. https:\/\/doi.org\/10.2353\/ajpath.2009.080888","journal-title":"Am J Pathol"},{"key":"5501_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1539\/joh.13-0172-oa","volume":"56","author":"S Nanayakkara","year":"2014","unstructured":"Nanayakkara S, Senevirathna ST, Abeysekera T, Chandrajith R, Ratnatunga N, Gunarathne ED, Yan J, Hitomi T, Muso E, Komiya T, Harada KH, Liu W, Kobayashi H, Okuda H, Sawatari H, Matsuda F, Yamada R, Watanabe T, Miyataka H, Himeno S, Koizumi A (2014) An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North central region of Sri Lanka. J Occup Health 56:28\u201338. https:\/\/doi.org\/10.1539\/joh.13-0172-oa","journal-title":"J Occup Health"},{"key":"5501_CR35","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.lfs.2008.04.015","volume":"82","author":"M Cesquini","year":"2008","unstructured":"Cesquini M, Stoppa GR, Prada PO, Torsoni AS, Romanatto T, Souza A, Saad MJ, Velloso LA, Torsoni MA (2008) Citrate diminishes hypothalamic acetyl-CoA carboxylase phosphorylation and modulates satiety signals and hepatic mechanisms involved in glucose homeostasis in rats. Life Sci 82:1262\u20131271. https:\/\/doi.org\/10.1016\/j.lfs.2008.04.015","journal-title":"Life Sci"},{"key":"5501_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543784.2019.1657825","volume":"28","author":"L Chen","year":"2019","unstructured":"Chen L, Duan Y, Wei H, Ning H, Bi C, Zhao Y, Qin Y, Li Y (2019) Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1\/2 inhibitors. Expert Opin Investig Drugs 28:917\u2013930. https:\/\/doi.org\/10.1080\/13543784.2019.1657825","journal-title":"Expert Opin Investig Drugs"},{"key":"5501_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","volume":"14","author":"AL Birkenfeld","year":"2011","unstructured":"Birkenfeld AL, Lee HY, Guebre-Egziabher F, Alves TC, Jurczak MJ, Jornayvaz FR, Zhang D, Hsiao JJ, Martin-Montalvo A, Fischer-Rosinsky A, Spranger J, Pfeiffer AF, Jordan J, Fromm MF, K\u00f6nig J, Lieske S, Carmean CM, Frederick DW, Weismann D, Knauf F, Irusta PM, De Cabo R, Helfand SL, Samuel VT, Shulman GI (2011) Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab 14:184\u201395. https:\/\/doi.org\/10.1016\/j.cmet.2011.06.009","journal-title":"Cell Metab"},{"key":"5501_CR38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.molmet.2016.08.004","volume":"5","author":"S Brachs","year":"2016","unstructured":"Brachs S, Winkel AF, Tang H, Birkenfeld AL, Brunner B, Jahn-Hofmann K, Margerie D, Ruetten H, Schmoll D, Spranger J (2016) Inhibition of citrate cotransporter Slc13a5\/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. Mol Metab 5:1072\u20131082. https:\/\/doi.org\/10.1016\/j.molmet.2016.08.004","journal-title":"Mol Metab"},{"key":"5501_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00424-013-1369-y","volume":"466","author":"AM Pajor","year":"2014","unstructured":"Pajor AM (2014) Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family. Pflugers Arch 466:119\u2013130. https:\/\/doi.org\/10.1007\/s00424-013-1369-y","journal-title":"Pflugers Arch"},{"key":"5501_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.mad.2010.08.006","volume":"131","author":"W Liu","year":"2010","unstructured":"Liu W, Hong Q, Bai XY, Fu B, Xie Y, Zhang X, Li J, Shi S, Lv Y, Sun X, Chen X (2010) High-affinity Na(+)-dependent dicarboxylate cotransporter promotes cellular senescence by inhibiting SIRT1. Mech Ageing Dev 131:601\u2013613. https:\/\/doi.org\/10.1016\/j.mad.2010.08.006","journal-title":"Mech Ageing Dev"},{"key":"5501_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111249","volume":"188","author":"PS Pardo","year":"2020","unstructured":"Pardo PS, Boriek AM (2020) SIRT1 regulation in ageing and obesity. Mech Ageing Dev 188:111249. https:\/\/doi.org\/10.1016\/j.mad.2020.111249","journal-title":"Mech Ageing Dev"},{"key":"5501_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L (2014) SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 25:138\u2013145. https:\/\/doi.org\/10.1016\/j.tem.2013.12.001","journal-title":"Trends Endocrinol Metab"},{"key":"5501_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00598","volume":"11","author":"S Guo","year":"2020","unstructured":"Guo S, Ma B, Jiang X, Li X, Jia Y (2020) Astragalus polysaccharides inhibits tumorigenesis and lipid metabolism through miR-138-5p\/SIRT1\/SREBP1 pathway in prostate cancer. Front Pharmacol 11:598. https:\/\/doi.org\/10.3389\/fphar.2020.00598","journal-title":"Front Pharmacol"},{"key":"5501_CR44","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nature02583","volume":"429","author":"F Picard","year":"2004","unstructured":"Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771\u20136. https:\/\/doi.org\/10.1038\/nature02583","journal-title":"Nature"},{"key":"5501_CR45","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X (2020) Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A 117:31189\u201331197. https:\/\/doi.org\/10.1073\/pnas.2017152117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5501_CR46","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/db18-1055","volume":"68","author":"C Zhang","year":"2019","unstructured":"Zhang C, Luo X, Chen J, Zhou B, Yang M, Liu R, Liu D, Gu HF, Zhu Z, Zheng H, Li L, Yang G (2019) Osteoprotegerin promotes liver steatosis by targeting the ERK-PPAR-\u03b3-CD36 pathway. Diabetes 68:1902\u20131914. https:\/\/doi.org\/10.2337\/db18-1055","journal-title":"Diabetes"},{"key":"5501_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2024.08.009","volume":"82","author":"YJ Liu","year":"2025","unstructured":"Liu YJ, Kimura M, Li X, Sulc J, Wang Q, Rodr\u00edguez-L\u00f3pez S, Scantlebery AML, Strotjohann K, Gallart-Ayala H, Vijayakumar A, Myers RP, Ivanisevic J, Houtkooper RH, Subramanian GM, Takebe T, Auwerx J (2025) ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD\/MASH. J Hepatol 82:174\u2013188. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.009","journal-title":"J Hepatol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05501-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:41:28Z","timestamp":1775637688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["5501"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05501-5","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal procedures were conducted in accordance with the Institutional Animal Care and Use Committee (IACUC) protocol of Zhejiang University (Ethics approval number: IACUC-s20-016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}